3,487
Views
8
CrossRef citations to date
0
Altmetric
Immunology

Real-world evidence costs of allergic rhinitis and allergy immunotherapy in the commercially insured United States population

, , , &
Pages 957-965 | Received 26 Jan 2021, Accepted 08 Mar 2021, Published online: 02 Apr 2021

Figures & data

Table 1. Demographic characteristics by AIT cohorts.

Table 2. Baseline clinical characteristics by AIT cohorts.

Table 3. All-cause and AR-related healthcare costs by AIT cohorts in the baseline and follow-up periods.

Figure 1. All-cause and AR-related cost differences baseline to follow-up by AIT cohorts.

Figure 1. All-cause and AR-related cost differences baseline to follow-up by AIT cohorts.

Figure 2. Cost distribution of index SCIT claims by select Current Procedural Terminology codes.

Figure 2. Cost distribution of index SCIT claims by select Current Procedural Terminology codes.